TORL BioTherapeutics: Funding, Investors & Team (Sep 2026)
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
TORL BioTherapeutics has raised $96.0M across 1 funding round on record, the most recent a Series C of $96.0M announced in Oct 2025.
That round is above the $42M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
TORL BioTherapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2025.
TORL BioTherapeutics Funding Rounds
TORL BioTherapeutics Founders and Leadership Team
Contact details for the TORL BioTherapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →TORL BioTherapeutics Funding Compared to Other Biotechnology Startups
TORL BioTherapeutics' latest round of $96.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like TORL BioTherapeutics in Biotechnology and Culver City
Companies Similar to TORL BioTherapeutics
Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and…
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific…
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal…
Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.
ThirdLaw Molecular pioneers revolutionary Spiroligomer™ molecules for safer, more targeted, effective disease…
Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain…
Weike Bio is a gene therapy drug development company.
Twinpig Biolab researches and develops anticancer drugs.
Kunshi Biotechnology is a drug developer with an emphasis on solid tumor cells.
BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.
Step Pharma is a biotechnology company.
TORL BioTherapeutics Funding FAQs
What does TORL BioTherapeutics do?
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
How much funding has TORL BioTherapeutics raised?
TORL BioTherapeutics has raised $96.0M across 1 round on record. The most recent is a Series C of $96.0M announced in Oct 2025.
When did TORL BioTherapeutics last raise funding?
TORL BioTherapeutics' most recent funding round on record is a Series C of $96.0M, announced in Oct 2025.
Who is the CEO of TORL BioTherapeutics?
Mark Alles is listed as CEO at TORL BioTherapeutics.
Where is TORL BioTherapeutics headquartered?
TORL BioTherapeutics is based in Culver City, United States.
How many employees does TORL BioTherapeutics have?
TORL BioTherapeutics is in the 11-50 employee band.
How does TORL BioTherapeutics' funding compare to other Biotechnology startups?
TORL BioTherapeutics' latest round of $96.0M is above the $42M median round size for Biotechnology companies on FundedIQ across 20 tracked companies over the last two years.
About FundedIQ's TORL BioTherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for TORL BioTherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.